Category 2019

PROTACs go macrocyclic

Check our latest paper published in Angewandte. Closing the circle: A macrocyclic PROTAC has been designed and synthesized by adding a cyclizing linker to MZ1, a PROTAC targeting the bromodomain of the BET protein, Brd4. A co‐crystal structure of macroPROTAC‐1…

University of Dundee and Eisai enter partnership 

University of Dundee and Eisai enter partnership for cancer drug discovery using targeted protein degradation. Read the full press release from Eisai Related links Eisai PR: EISAI ENTERS INTO COLLABORATION RESEARCH AGREEMENT WITH UNIVERSITY OF DUNDEE ON TARGETED PROTEIN DEGRADATION…

XXVI National Meeting in Medicinal Chemistry (NMMC 2019)

Alessio delivers one of the plenary lectures at the XXVI National Meeting in Medicinal Chemistry (NMMC 2019) in Milan, Italy. Read more about conference in the ChemMedChem’s Editorial: “Overview of the XXVI National Meeting in Medicinal Chemistry” by Prof. Marina Carini and Prof.…